Researchers have proven that sufferers with acute COVID-19 an infection have elevated ranges of the cytokine IL-26 of their blood. Furthermore, excessive IL-26 ranges correlate with an exaggerated inflammatory response that signifies extreme instances of the illness. The findings point out that IL-26 is a possible biomarker for extreme COVID-19.